Telik Inc (NASDAQ:TELK)

CAPS Rating: 2 out of 5

A biopharmaceutical company working to discover, develop and commercialize innovative small molecule drugs to treat diseases.

Recs

0
Player Avatar target213 (< 20) Submitted: 10/10/2006 3:43:10 PM : Outperform Start Price: $528.69 TELK Score: -102.65

I think there will be news regarding their drug line

Report this Post Reply

Featured Broker Partners


Advertisement